Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute myeloid leukemia
Cancers | Free Full-Text | Outcome of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study
Blinatumomab Effective for Children with Relapsed Leukemia - NCI
A) Overall survival, (B) relapse-free survival, and (C) event-free... | Download Scientific Diagram
Single‑cell RNA sequencing of t(8;21) acute myeloid leukemia for risk prediction
Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram
View Image
Figure 3 from Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. | Semantic Scholar
Prognostic factors and treatment of pediatric acute lymphoblastic leukemia
Kaplan-Meier overall survival and event free survival curves of acute... | Download Scientific Diagram
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica
Treatment of Acute Lymphoblastic Leukemia -- 30 Years' Experience at St. Jude Children's Research Hospital | NEJM
ASH 2022: FLAG-Ida Combined with Gemtuzumab Ozogamicin (GO) Improves Event Free Survival in Younger Patients with Newly Diagnosed Acute Myeloid Leukaemia (AML) and Shows an Overall Survival Benefit in NPM1 and FLT3
Event free survival of 71 children with acute lymphoblastic leukemia... | Download Scientific Diagram
Overall survival and event-free survival according to primary... | Download Scientific Diagram
Event-free survival (EFS) and overall survival (OS) according to risk... | Download Scientific Diagram
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology
Acute Lymphoblastic Leukemia | NEJM
Kaplan-Meier survival curves of event-free survival (EFS) and overall... | Download Scientific Diagram
Reduced–dose intensity therapy for pediatric lymphoblastic leukemia: long-term results of the Recife RELLA05 pilot study - ScienceDirect
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library
Kaplan-Meier overall survival (OS) and event-free survival (EFS)... | Download Scientific Diagram
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer
